News & Events
ASNR 2022 Annual Meeting
Attending ASNR22? Stop by Booth #109 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
Combinostics Selected to Progress to the Finals of neurotechprize
Combinostics has been selected by the jury to progress to the finals for the neurotechprize run by EIT Health and Biogen. The award recognizes technological innovations for the diagnosis and care of Alzheimer’s patients.
Combinostics Not Impacted by Apache Log4j Vulnerability
We are confident that Combinostics is not affected by the recent vulnerabilities found in Apache Log4j. We will continue to track updates relating to this vulnerability.
Combinostics Demonstrates Latest cNeuro® Features and Applications at RSNA 2021
Combinostics will demonstrate the features of cNeuro® 2.0, the latest release to their AI-based suite of products, and applications under development at RSNA 2021.
Arterys Partners with Combinostics to Accelerate Accurate and Consistent Evaluations of Patients with Neurodegenerative Disease and Multiple Sclerosis
Arterys has partnered with Combinostics to offer the most comprehensive neuro AI suite on the market, covering a broad set of applications in neuroradiology .
Combinostics Announces Addition of Greg Kingston as Chief Marketing Officer
Greg Kingston joins the Combinostics leadership team as Chief Marketing Officer (CMO). He has more than a decade of experience in the medical imaging software domain and a focus in AI-based technology.
RSNA 2021
Attending RSNA 2021? Stop by Booth #4937 in the AI Showcase and chat about cMRI, cDSI and more for automated MRI biomarker detection and quantification.
cNeuro 2.0
Combinostics today announced the release of cNeuro® cMRI 2.0 and cNeuro® cDSI 2.0.
Richard Hausmann Appointed as CEO of Combinostics
Richard Hausmann has been named Chief Executive Officer, effective June 1, 2021. Hausmann will succeed Lennart Thurfjell, who will transition to the role of Chief Operating Officer.
